John G. Singer on LI: Eli Lilly strikes drug dispensing deal with Amazon

John G. Singer, an executive at Blue Spoon Consulting, discusses the transformation required within the pharmaceutical industry beyond conventional marketing strategies. Pfizer and Amazon are highlighted as an example of direct distribution, emphasizing a novel approach to pharmaceutical distribution and market access innovation. This strategic shift aims to disrupt the traditional economic systems influenced by pharmacy benefit managers and employee benefits consultants, thereby reshaping how pharmaceuticals create market dynamics and customer experiences. Additionally, XO2Tech™ introduces an AI-Robot-Companion™ that marks a significant advancement in healthcare technology by integrating wearables, robotics, and AI to offer continuous healthcare monitoring and personalized care recommendations, also emphasizing the need for a holistic and patient-centric approach in healthcare technology development.

Opens on LinkedIn